Overview

Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if there is an interest to optimize HF (heart failure) management in patients over 80 years old. The primary objective is to assess the effect of HF (heart failure) optimized management (guidelines of the European society of Cardiology (ESC) on Quality of Life (QOL) in aged over 80 year's old at 6 months.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborators:
LivaNova
Servier
Treatments:
Captopril
Enalapril
Enzyme Inhibitors
Lisinopril
Ramipril
Trandolapril